|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/451 | (2006.01) |
| A61P 25/28 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/451 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Patento numeris | 3570940 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18741607.8 |
| Europos patento paraiškos padavimo data | 2018-01-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/014169 |
| Data | 2018-01-18 |
| (87) | Numeris | WO 2018/136600 |
| Data | 2018-07-26 |
| (30) | Numeris | Data | Šalis |
| 201762448595 P | 2017-01-20 | US |
| (72) |
HAYDEN, Michael , IL
POULADI, Mahmoud, Abdulhossein , SG
|
| (73) |
Prilenia Neurotherapeutics Ltd. ,
10 HaMenofim Street, 4672561 Herzliya,
IL
National University of Singapore , 21 Lower Kent Ridge Road, Singapore 119077, SG Agency for Science, Technology and Research , 1 Fusionopolis Way 20-10 Connexis North, Singapore 138632, SG |
| (54) | PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME |
| PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME |